Scholar IQ
Try ScholarIQ free
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Clostridium difficile and Clostridium perfringens research

TopicLeading institutions, researchers & key papers

Clostridium difficile and Clostridium perfringens research is a topic indexed in ScholarIQ from OpenAlex.

What is known about Clostridium difficile and Clostridium perfringens research?

ScholarIQrecord summary

This cluster of papers focuses on the epidemiology, treatment, and prevention of Clostridium difficile infection, with a particular emphasis on fecal microbiota transplantation, antibiotic-associated diarrhea, healthcare-associated infections, toxin production, and clinical practice guidelines. It also explores the role of microbiome diversity, vancomycin and metronidazole treatment, risk factors for infection, and bacterial toxins associated with the disease.

How many works does Clostridium difficile and Clostridium perfringens research have?

ScholarIQindexed works

Clostridium difficile and Clostridium perfringens research has 306 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Clostridium difficile and Clostridium perfringens research?

ScholarIQopenalex

The OpenAlex for Clostridium difficile and Clostridium perfringens research is on the source record.

What are the most-cited papers on Clostridium difficile and Clostridium perfringens research?

ScholarIQmost cited works
Duodenal Infusion of Donor Feces for Recurrent <i>Clostridium difficile</i>
Els van Nood, Anne Vrieze, Max Nieuwdorp, Susana Fuentes, Erwin G. Zoetendal, Willem M. de Vos, Caroline E. Visser, Ed J. Kuijper, J. F. W. M. Bartelsman, Jan G.P. Tijssen, Peter Speelman, Marcel G. W. Dijkgraaf, Josbert J. Keller
New England Journal of Medicine. 20133,700 CitationsOPEN ACCESS
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel, Rona Ortenberg, Adi Lahat, Lior H. Katz, Katerina Adler, Daniela Dick‐Necula, Stephen Raskin, Naamah Bloch, Д. Л. Ротин, Liat Anafi, Camila Avivi, Jenny Melnichenko, Yael Steinberg‐Silman, Ronac Mamtani, Hagit Harati, Nethanel Asher, Ronnie Shapira‐Frommer, Tal Brosh‐Nissimov, Yael Eshet, Shira Ben-Simon, Ziv Oren, Md Abdul Wadud Khan, Moran Amit, Nadim J. Ajami, Iris Barshack, Jacob Schachter, Jennifer A. Wargo, Omry Koren, Gal Markel, Ben Boursi
Science. 20201,664 Citations
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi, Michael G. Surette, Peter T. Kim, Josie Libertucci, Melanie Wolfe, Catherine Onischi, David Armstrong, John K. Marshall, Zain Kassam, Walter Reinisch, Christine H. Lee
Gastroenterology. 20151,512 CitationsOPEN ACCESS
Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp, Patricia P. Bloom, Mariam Torres Soto, Michael K. Mansour, Mohamad Sater, Miriam Huntley, Sarah E. Turbett, Raymond T. Chung, Yi‐Bin Chen, Elizabeth Hohmann
New England Journal of Medicine. 20191,207 CitationsOPEN ACCESS
European consensus conference on faecal microbiota transplantation in clinical practice
Giovanni Cammarota, Gianluca Ianiro, Herbert Tilg, Mirjana Rajilić–Stojanović, Patrizia Kump, Reetta Satokari, Harry Sokol, Perttu Arkkila, C. Pintus, Ailsa Hart, Jonathan Segal, Marina Aloi, Luca Masucci, Antonio Molinaro, Franco Scaldaferri, Antonio Gasbarrini, Antonio López–Sanromán, Alexander Link, Pieter F. de Groot, Willem M. de Vos, Christoph Högenauer, Peter Malfertheiner, Eero Mattila, Tomica Milosavljević, Max Nieuwdorp, Maurizio Sanguinetti, Magnus Simrén, Antonio Gasbarrini
Gut. 20171,173 CitationsOPEN ACCESS

Where is Clostridium difficile and Clostridium perfringens research research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Clostridium difficile and Clostridium perfringens research is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
0%
Green
13%
Hybrid
13%
Bronze
33%
Closed
40%

Related on ScholarIQ

Duodenal Infusion of Donor Feces for Recurrent <i>Clostridium difficile</i>
Paper
The gut microbiota and host health: a new clinical frontier
Paper
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis
Paper
Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella
Paper
Composition, variability, and temporal stability of the intestinal microbiota of the elderly
Paper
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Paper
470M+ articles · 14-day free trial